ly 293111 has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreeff, M; Konopleva, M; McQueen, T; Rassidakis, G; Schober, W; Zhang, W | 1 |
1 other study(ies) available for ly 293111 and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation.
Topics: Apoptosis; Benzoates; Cell Cycle; Cell Cycle Proteins; Cyclin E; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Down-Regulation; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Kinase 4; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Reactive Oxygen Species; Receptors, Leukotriene B4; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation | 2005 |